MTNB icon

Matinas BioPharma
MTNB

Overview Fund Activity

49 hedge funds and large institutions have $13M invested in Matinas BioPharma in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+1
Holders Change %
+2.08%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
23
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
American Century Companies
1
American Century Companies
Missouri
$155K
2
BCM
2
Bridgeway Capital Management
Texas
$219K
3
Deutsche Bank
3
Deutsche Bank
Germany
$171K
4
BlackRock
4
BlackRock
New York
$2.94M
5
Wells Fargo
5
Wells Fargo
California
$90K

Top Sellers

1
IA
1
IFP Advisors
Florida
$291K
2
AWMG
2
Alliance Wealth Management Group
New Jersey
$465K
3
AA
3
ALPS Advisors
Colorado
$0
4
IIA
4
IPG Investment Advisors
California
$0
5
State Street
5
State Street
Massachusetts
$980K
Name Holding Trade Value Shares
Change 		Shares
Change %
IIA
51
IPG Investment Advisors
California
– -$58.7K -890 Closed
Creative Planning
52
Creative Planning
Kansas
– -$49K -745 Closed
JPMPWA
53
J.P. Morgan Private Wealth Advisors
California
– -$40K -600 Closed
NFA
54
Nationwide Fund Advisors
Ohio
– -$39K -597 Closed
SO
55
STRS Ohio
Ohio
– -$20K -308 Closed
1 2
3